208 related articles for article (PubMed ID: 34994266)
1. The Potential for Natural Products to Overcome Cancer Drug Resistance by Modulation of Epithelial-Mesenchymal Transition.
Dahmardeh Ghalehno A; Boustan A; Abdi H; Aganj Z; Mosaffa F; Jamialahmadi K
Nutr Cancer; 2022; 74(8):2686-2712. PubMed ID: 34994266
[TBL] [Abstract][Full Text] [Related]
2. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
Du B; Shim JS
Molecules; 2016 Jul; 21(7):. PubMed ID: 27455225
[TBL] [Abstract][Full Text] [Related]
3. Roles of Dietary Phytoestrogens on the Regulation of Epithelial-Mesenchymal Transition in Diverse Cancer Metastasis.
Lee GA; Hwang KA; Choi KC
Toxins (Basel); 2016 May; 8(6):. PubMed ID: 27231938
[TBL] [Abstract][Full Text] [Related]
4. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
Mittal V
Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
[TBL] [Abstract][Full Text] [Related]
5. Epithelial to Mesenchymal Transition in Lung Cancer: Potential EMT-Targeting Natural Product-derived Compounds.
Chanvorachote P; Petsri K; Thongsom S
Anticancer Res; 2022 Sep; 42(9):4237-4246. PubMed ID: 36039426
[TBL] [Abstract][Full Text] [Related]
6. Epithelial-mesenchymal transition and drug resistance: role, molecular mechanisms, and therapeutic strategies.
Sui H; Zhu L; Deng W; Li Q
Oncol Res Treat; 2014; 37(10):584-9. PubMed ID: 25342509
[TBL] [Abstract][Full Text] [Related]
7. Polyphyllin I Overcomes EMT-Associated Resistance to Erlotinib in Lung Cancer Cells via IL-6/STAT3 Pathway Inhibition.
Lou W; Chen Y; Zhu KY; Deng H; Wu T; Wang J
Biol Pharm Bull; 2017 Aug; 40(8):1306-1313. PubMed ID: 28515374
[TBL] [Abstract][Full Text] [Related]
8. Anti-Cancer Potential of Phytochemicals: The Regulation of the Epithelial-Mesenchymal Transition.
Liu S; Li L; Ren D
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446730
[TBL] [Abstract][Full Text] [Related]
9. Role of phytochemicals in the inhibition of epithelial-mesenchymal transition in cancer metastasis.
Kim EK; Choi EJ; Debnath T
Food Funct; 2016 Sep; 7(9):3677-85. PubMed ID: 27507108
[TBL] [Abstract][Full Text] [Related]
10. FGFR signaling maintains a drug persistent cell population following epithelial-mesenchymal transition.
Brown WS; Akhand SS; Wendt MK
Oncotarget; 2016 Dec; 7(50):83424-83436. PubMed ID: 27825137
[TBL] [Abstract][Full Text] [Related]
11. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
Erin N; Grahovac J; Brozovic A; Efferth T
Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
[TBL] [Abstract][Full Text] [Related]
12. The novel role of Yin Yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NF-κB/Snail/YY1/RKIP/PTEN Circuitry.
Bonavida B; Baritaki S
Crit Rev Oncog; 2011; 16(3-4):211-26. PubMed ID: 22248055
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy.
Chen HT; Liu H; Mao MJ; Tan Y; Mo XQ; Meng XJ; Cao MT; Zhong CY; Liu Y; Shan H; Jiang GM
Mol Cancer; 2019 May; 18(1):101. PubMed ID: 31126310
[TBL] [Abstract][Full Text] [Related]
14. Luteolin and cancer metastasis suppression: focus on the role of epithelial to mesenchymal transition.
Hussain Y; Cui JH; Khan H; Aschner M; Batiha GE; Jeandet P
Med Oncol; 2021 May; 38(6):66. PubMed ID: 33950369
[TBL] [Abstract][Full Text] [Related]
15. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.
Garg M
Expert Opin Ther Targets; 2015 Feb; 19(2):285-97. PubMed ID: 25563894
[TBL] [Abstract][Full Text] [Related]
16. Association of the Epithelial-Mesenchymal Transition (EMT) with Cisplatin Resistance.
Ashrafizadeh M; Zarrabi A; Hushmandi K; Kalantari M; Mohammadinejad R; Javaheri T; Sethi G
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32503307
[TBL] [Abstract][Full Text] [Related]
17. Roles of epithelial-mesenchymal transition in cancer drug resistance.
Shang Y; Cai X; Fan D
Curr Cancer Drug Targets; 2013 Nov; 13(9):915-29. PubMed ID: 24168191
[TBL] [Abstract][Full Text] [Related]
18. Diverse pathways of epithelial mesenchymal transition related with cancer progression and metastasis and potential effects of endocrine disrupting chemicals on epithelial mesenchymal transition process.
Lee HM; Hwang KA; Choi KC
Mol Cell Endocrinol; 2017 Dec; 457():103-113. PubMed ID: 28042023
[TBL] [Abstract][Full Text] [Related]
19. CD44 Facilitates Epithelial-to-Mesenchymal Transition Phenotypic Change at Acquisition of Resistance to EGFR Kinase Inhibitors in Lung Cancer.
Suda K; Murakami I; Yu H; Kim J; Tan AC; Mizuuchi H; Rozeboom L; Ellison K; Rivard CJ; Mitsudomi T; Hirsch FR
Mol Cancer Ther; 2018 Oct; 17(10):2257-2265. PubMed ID: 30049789
[TBL] [Abstract][Full Text] [Related]
20. EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer.
Haslehurst AM; Koti M; Dharsee M; Nuin P; Evans K; Geraci J; Childs T; Chen J; Li J; Weberpals J; Davey S; Squire J; Park PC; Feilotter H
BMC Cancer; 2012 Mar; 12():91. PubMed ID: 22429801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]